Currently, prostate cancer prognosis is based on age, elevated levels of PSA, and a prostatic digital rectal examination (DRE) often followed by prostate biopsy [19], none of which can distinguish between BPH and prostate cancer [18]. This evidence concerns the gene KLK3 and prostate carcinoma.